Schedule Your Free Consultation

Bayer Rebuked As Yaz Blood Clot MDL Case Gets Trial Date

Yaz-Birth Control - Packaging

Bayer HealthCare Pharmaceuticals Inc. has been facing multidistrict litigation since 2009 when thousands of women filed claims alleging serious stroke risks of Yaz, Bayer's birth control drug. On February 13th, Illinois Federal Judge David Herndon set a June trial date for one of the suits in the litigation. With thousands of women's Yaz and Yasmin claims unresolved, Judge Herndon says Bayer is using attrition as part of its defense strategy to wear people down.

Pamela Schuchert's suit has been set for trial to begin on June 15, 2015, before Judge Herndon. She claims that she suffered a stroke after taking Yaz, as the synthetic hormone in the drug called drospirenone can cause heart problems, blood clots, and strokes, something Bayer should have been aware of.

Judge Herndon states that Bayer has slowed down the proceedings by refusing to waive venue requirements that the Court needs in order to establish a bellwether process for selecting a series of trials in the MDL. He has now remanded groups of cases back to U.S. District Courts across the country for individual trials to proceed later this year.

Click here to read the full story.

Categories

Why Choose Our Firm?

  • Over 50 Years of Experience
  • Honest and Personalized Communication
  • Dedicated to Helping You Get Your Life Back
  • Committed to Our Community
  • Compassionate in Our Approach

An Experienced Team
You Can Trust

/

More Than A Case

Our Clients Are Our Priority
  • “When my frustrations with the process were heightened, my representative calmly explained how this type of litigation usually proceeds.”

    - Phil N.
  • “Kristin always kept us updated and advised us as to what our next steps should be.”

    - Dick K.

Contact Us

Schedule Your Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.